FIRST SCIENTIFIC STUDY ON HUMANS WITH CHLORINE DIOXIDE FOR THERAPEUTIC USE

September 19th, 2021

Awake Goy

A hope to end the COVID-19 pandemic.

The clinical study showed that chlorine dioxide is effective in patients treated with oral ClO2 and that its use in the COVID-19 pandemic becomes and positions itself as a great hope to control it, based on the scientific foundations revealed in previous research .

Chlorine dioxide was shown to be beneficial in the treatment of COVID-19, making negative RT-PCR at 7 days in one hundred percent of the patients who took it during the clinical study, rapidly mitigating their symptoms associated with this disease, and significantly reducing the laboratory parameters to normal in a space of 14 to 21 days.

In addition, the researchers observed that patients who consumed chlorine dioxide as a treatment for COVID-19 also substantially reduced post-illness symptoms, compared to patients not treated with ClO2.

We are facing a solution that can end the pandemic, now scientifically proven.

CDS saves lives! You now have the opportunity to read the first multicenter clinical study carried out in several Latin American countries that clearly demonstrates that chlorine dioxide is a totally effective treatment against COVID-19

Read all studies:

https://andreaskalcker.com/en/coronavirus/clinical-study-with-chlorine-dioxide.html

You now have the opportunity to read the first multicenter clinical study carried out in several Latin American countries that clearly demonstrates that chlorine dioxide is a fully effective treatment against COVID-19.

The highly satisfactory results of the first multicenter clinical study in humans, on the effectiveness of chlorine dioxide (ClO²) as CDS in the treatment of COVID-19, were successfully published in the scientific journal Journal of Molecular and Genetic Medicine (ISSN: 1747-0862).

The study was registered and accepted in clinicaltrials.gov on April 7, 2020 (NCT 04343742) and falls within the studies categorized as ECE (quasi-experimental studies) by the NCBI (National Center for Biotechnology Information).

This is the first clinical study with chlorine dioxide for therapeutic use in humans, demonstrating with scientific evidence its effectiveness and safety in the treatment for COVID-19. The research focused on studying the effectiveness of the use of ClO2 in patients with SARS-CoV-2, measuring before and after treatment, the clinical symptoms present and laboratory variables based on standardized and accepted scales in research (VAS and Likert) of an experimental group, compared to a control group.

A hope to end the COVID-19 pandemic

We are facing a solution that can end the pandemic, now scientifically proven: CDS works and saves lives!

Following this clinical study, physicians around the world now have the right to legally use chlorine dioxide in accordance with the paragraph 37 of the Declaration of Helsinki *. The therapeutic use of chlorine dioxide gives new hope to end the COVID-19 pandemic and save millions of lives.

The Declaration of Helsinki has been promulgated by the World Medical Association as a body of ethical principles that should guide the medical community, and in paragraph 37 it states the following: ales _

“When proven interventions do not exist in the care of a patient or other known interventions have been ineffective, the physician, after seeking expert advice, with the informed consent of the patient or an authorized legal representative, may be allowed to use unproven interventions, if, in his opinion, this gives some hope of saving life, restoring health or alleviating suffering. Such interventions should be further investigated in order to assess their safety and efficacy. In all cases, this new information must be recorded and, when appropriate, made available to the public. “

Chlorine dioxide is approved by law in Bolivia

In Bolivia, Law No. 1351 of 2020 was approved that authorized the preparation, commercialization, supply and use under consent of the CDS chlorine dioxide solution, as prevention and treatment in the face of the COVID-19 pandemic. An ethics committee was legally constituted endorsed by the Bolivian Ministry of Health, which approved this multicenter, retrospective, international research protocol, made up of five universities (Technical University of Oruro, Public University of El Alto, Greater University of San Simón , Universidad Autónoma Gabriel René Moreno and the Technical Institute of Yacuiba “Gran Chaco”) which in turn, through their clinical, scientific and ethical research committees, are conducting their own research on chlorine dioxide for use in different Applications.

Statistics from Bolivia show a marked reduction in cases and deaths in that country. For example, from a peak of 2031 daily cases on August 20, 2020, cases dropped to 147 daily cases on October 21, 2020, representing a 93% decrease.

While in other countries the increase in mortality was maintained, in Bolivia it fell, attributing this decrease to the consumption of chlorine dioxide as a possible explanation.

In other Latin American countries, chlorine dioxide is also beginning to be used with great success to combat COVID-19, as, for example, do the doctors who make up the COMUSAV, World Health and Life Coalition (www.comusav.com) who apply it to their patients with excellent results.

Therapeutic action of chlorine dioxide

The therapeutic action of chlorine dioxide against COVID-19 is given by its selectivity for pH and viral size. This means that the ClO² it dissociates and releases oxygen when it comes into contact with the virus. When it dissociates, it oxidizes the present spikes of acidic pH and becomes sodium chloride (common salt) and at the same time releases molecular oxygen O², which in turn helps local cell recovery. Therefore, when chlorine dioxide dissociates, it releases oxygen just like erythrocytes (red blood cells) through the same principle, which is to be selective for acidity (Bohr effect). Chlorine dioxide releases molecular oxygen when it encounters an acidic environment, either through histamine or the acidity of the virus itself. The ClO² is an antimicrobial agent whose action is selective by size and therefore It does not affect human cells due to its large size compared to the virus and it is extremely effective on all types of viruses including COVID-19 with all its variants and strains.

Multicellular tissue has the ability to dissipate this charge and is therefore not affected. A great advantage of the therapeutic use of ClO², is the impossibility of a viral resistance.

The cause of the antiviral effect of chlorine dioxide in SARS-CoV-2 can be explained by its actions on the amino acids of the virus (cysteine, tryptophan, tyrosine, proline, hydroxyproline).

It is the first scientific study in humans with chlorine dioxide for therapeutic use that indicates clear efficacy that must be investigated without fail, with larger studies to save many thousands of lives.

This exceptional study has been registered and accepted in clinicaltrials.gov on April 7, 2020 (NCT 04343742) and falls within the studies categorized as ECE (quasi-experimental pilot studies) by the NCBI (National Center for Biotechnology Information).

https://andreaskalcker.com/en/